Evaluation of diagnostic performance of new antigen-based enzyme immune assay for diagnosis of Hepatitis C virus (HCV) infections
dc.authorid | özer, ali/0000-0002-7144-4915; | |
dc.authorwosid | özer, ali/ABI-2209-2020 | |
dc.authorwosid | YAKUPOGULLARI, YUSUF/F-3966-2011 | |
dc.contributor.author | Kooglu, Mehmet | |
dc.contributor.author | Ak, Sibel | |
dc.contributor.author | Ak, Muharrem | |
dc.contributor.author | Yakupogullari, Yusuf | |
dc.contributor.author | Ozer, Ali | |
dc.date.accessioned | 2024-08-04T20:58:44Z | |
dc.date.available | 2024-08-04T20:58:44Z | |
dc.date.issued | 2012 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Laboratory diagnosis of Hepatitis C virus (HCV) is sometimes problematic. A novel immune enzyme assay (HCV-Core Antigen, Abbott Laboratories/Germany) has been recently licensed for detection of HCV antigen in human serum. In this study, we aimed to evaluate diagnostic performance of this new test in comparison with the HCV-RNA quantification and anti-HCV antibody (anti-HCV-Ab) analyses. A total of 152 serum samples of which 112 anti-HCV-Ab positive (range 1.08 to 386.54 s/co) and 40 anti-HCV-Ab negative (<1 s/co) were analyzed with HCV-RNA and HCV-Ag tests. According to HCV-RNA detection, sensitivity and specificity of HCV-Ag test was measured as 96.9 and 100%, respectively and of anti-HCV-Ab were measured as 100 and 60%, orderly. An excellent positive predictive value for HCV-Ag test was detected as 100%, whereas 28.5% for anti-HCV-Ab test. Pearson correlation analysis showed that there was a statistically significant and strong relationship (p < 0.001, R: 0.773) between HCV-Ag and HCV-RNA quantification analysis. The correlation between the two tests showed an exponential trend (R-2: 0.949). These results suggest that HCV-Ag test may be a reliable assay for HCV antigen detection, which is also well-correlated with serum viral load. However, large studies, including different HCV genotypes and with extreme viral quantity, are required to assess analytic potency of this novel kit. | en_US |
dc.identifier.doi | 10.5897/AJMR11.1130 | |
dc.identifier.endpage | 812 | en_US |
dc.identifier.issn | 1996-0808 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 809 | en_US |
dc.identifier.uri | https://doi.org/10.5897/AJMR11.1130 | |
dc.identifier.uri | https://hdl.handle.net/11616/103107 | |
dc.identifier.volume | 6 | en_US |
dc.identifier.wos | WOS:000306480900015 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Academic Journals | en_US |
dc.relation.ispartof | African Journal of Microbiology Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hepatitis C | en_US |
dc.subject | diagnosis | en_US |
dc.subject | ELISA | en_US |
dc.subject | HCV core antigen | en_US |
dc.subject | HCV-RNA | en_US |
dc.title | Evaluation of diagnostic performance of new antigen-based enzyme immune assay for diagnosis of Hepatitis C virus (HCV) infections | en_US |
dc.type | Article | en_US |